Combating Bloodstream Infections: Diagnostics, Resistance, and Prevention
Received Date: Nov 03, 2025 / Published Date: Dec 01, 2025
Abstract
Bloodstream infections (BSIs) pose a significant global health burden, necessitating advancements in diagnostics, antimicrobial
stewardship, and early, targeted therapy. The persistent threat of antimicrobial resistance (AMR) drives the need for novel treatment
strategies and optimized stewardship programs. Rapid molecular diagnostics are improving pathogen identification, while fungal
BSIs and sepsis-associated delirium require specialized management. The emergence of multidrug-resistant organisms like CRE
complicates treatment, emphasizing the importance of new antimicrobial agents and infection control. Biomarkers assist in diagnosis
and therapy guidance, and understanding BSIs in the context of vector-borne diseases is crucial. Vaccine development represents a
key preventive measure against BSIs.
Citation: 脗聽DeLuca DM (2025) Combating Bloodstream Infections: Diagnostics, Resistance, and Prevention. J Clin Infect Dis Pract 10: 331.
Copyright: 漏 2025 Dr. Marco DeLuca This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits聽unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
Article Usage
- Total views: 217
- [From(publication date): 0-0 - Apr 06, 2026]
- Breakdown by view type
- HTML page views: 162
- PDF downloads: 55
